Fig. 2.
Fig. 2. Expression of Mac-1 on long-term reconstituting stem cells from normal and 5-FU–treated bone marrow. Erythrocyte-depleted WBM was collected from normal and 5-FU–treated mice, stained with anti–Mac-1, and sorted into 3 populations as indicated (A, normal; C, 5-FU); the relative representation is shown as a percent within each gate. WBM cells from normal mice were sorted into Mac-1− (32% of bone marrow), Mac-1low (15%), and Mac-1high (53%) populations from Ly5.2-expressing mice. The equivalent of 2 × 105 WBM cells from each population was injected into irradiated Ly5.1 recipients in competition with 2 × 105 Ly5.1 WBM cells. Thus, 0.64 × 105 cells of the Mac-1− population were injected per recipient, 0.3 × 105 cells of the Mac-1low population per recipient, and 1.06 × 105 cells of the c-kithigh population per recipient. The equivalent populations were sorted from 5-FU–treated Ly5.2 mice and 0.62 × 105 cells of the Mac-1− cells, 0.22 × 105 of the Mac-1low cells, and 1.16 × 105 of the Mac-1high cells were injected per irradiated Ly5.1 recipient in competition with 2 × 105 Ly5.1 WBM cells. Recipient mice were assayed for donor-type reconstitution after at least 16 weeks postreconstitution and the percent of donor-derived cells in each lineage was determined for each recipient of Mac-1−, Mac-1low, or Mac-1high cells (B, normal; D, 5-FU). The long-term reconstitution data for mice that received 5-FU–treated bone marrow represents the sum of 2 independent experiments with 5 mice in each group.

Expression of Mac-1 on long-term reconstituting stem cells from normal and 5-FU–treated bone marrow. Erythrocyte-depleted WBM was collected from normal and 5-FU–treated mice, stained with anti–Mac-1, and sorted into 3 populations as indicated (A, normal; C, 5-FU); the relative representation is shown as a percent within each gate. WBM cells from normal mice were sorted into Mac-1 (32% of bone marrow), Mac-1low (15%), and Mac-1high (53%) populations from Ly5.2-expressing mice. The equivalent of 2 × 105 WBM cells from each population was injected into irradiated Ly5.1 recipients in competition with 2 × 105 Ly5.1 WBM cells. Thus, 0.64 × 105 cells of the Mac-1 population were injected per recipient, 0.3 × 105 cells of the Mac-1low population per recipient, and 1.06 × 105 cells of the c-kithigh population per recipient. The equivalent populations were sorted from 5-FU–treated Ly5.2 mice and 0.62 × 105 cells of the Mac-1 cells, 0.22 × 105 of the Mac-1low cells, and 1.16 × 105 of the Mac-1high cells were injected per irradiated Ly5.1 recipient in competition with 2 × 105 Ly5.1 WBM cells. Recipient mice were assayed for donor-type reconstitution after at least 16 weeks postreconstitution and the percent of donor-derived cells in each lineage was determined for each recipient of Mac-1, Mac-1low, or Mac-1high cells (B, normal; D, 5-FU). The long-term reconstitution data for mice that received 5-FU–treated bone marrow represents the sum of 2 independent experiments with 5 mice in each group.

Close Modal

or Create an Account

Close Modal
Close Modal